Americas (WHO region) vs Sri Lanka: Confirmed cases of MDR-TB started treatment for MDR-TB
Americas (WHO region)
92.0%
in 2012
Sri Lanka
100.0%
in 2012
Americas (WHO region) rank
2nd
Sri Lanka rank
3rd
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Americas (WHO region)
- Sri Lanka
How they compare
Sri Lanka currently reports 100.0% against 92.0% in Americas (WHO region), a difference of 8.0%.
That makes Sri Lanka's figure about 1.1 times Americas (WHO region)'s.
The two have swapped places 1 time across 5 shared years of data; in 2008 it was Americas (WHO region) ahead.
Americas (WHO region) ranks 2nd and Sri Lanka ranks 3rd of 10 groups.
Americas (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 101.0% | 81.5% | 19.5% | Americas (WHO region) |
| 2010s | 88.0% | 71.0% | 17.0% | Americas (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Americas (WHO region) or Sri Lanka?
- Sri Lanka, at 100.0% against 92.0% in Americas (WHO region) as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Americas (WHO region) and Sri Lanka?
- 8.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Americas (WHO region) and Sri Lanka?
- 5 years are reported by both, from 2008 to 2012.
- How do Americas (WHO region) and Sri Lanka rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Americas (WHO region) ranks 2nd and Sri Lanka ranks 3rd of 10 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.